🔗 Visit the ClinicalTrials.gov page for NCT00923117
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Cancer statistics, 2007. | CA Cancer J Clin | 2007 | 53.49 |
| 2 | Experimental approaches for the treatment of malignant gliomas. | Pharmacol Ther | 2010 | 1.23 |
| 3 | A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. | Neuro Oncol | 2003 | 1.15 |
| 4 | Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. | J Neurooncol | 2011 | 0.99 |
| 5 | Unique biology of gliomas: challenges and opportunities. | Trends Neurosci | 2012 | 0.87 |
| 6 | Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial. | Am J Clin Oncol | 1996 | 0.85 |
| 7 | Activation of alternate prosurvival pathways accounts for acquired sunitinib resistance in U87MG glioma xenografts. | J Pharmacol Exp Ther | 2012 | 0.82 |
| 8 | Combining drugs and radiotherapy: from the bench to the bedside. | Curr Opin Neurol | 2009 | 0.81 |